Pre-implantation genetic diagnosis (PGD) is the process of evaluating embryos or oocytes for genetic abnormalities before they are implanted. It was created for couples who are concerned about severe Mendelian disorders, structural chromosome abnormalities, or mitochondrial illnesses in their offspring. In vitro fertilisation, embryo biopsy, and either fluorescence in situ hybridization or polymerase chain reaction at the single cell level are required for pre-implantation embryo diagnosis. As a result, it is a difficult technique that necessitates a great deal of expertise. Preimplantation genetic testing is a set of genetic tests performed to assess embryos before they are implanted in the uterus. Preimplantation genetic testing-monogenic is a narrower test that looks for aneuploidy in all chromosomes, including the 22 pairs of autosomes and the sex chromosomes X and Y. Preimplantation genetic testing-aneuploidy is a broader test that looks for aneuploidy in all chromosomes, including the 22 pairs of autosomes and the sex chromosomes X and Y. Preimplantation genetic testing-structural rearrangements is used to screen embryos for chromosome gains and losses caused by parental structural chromosomal abnormalities (e.g., translocations, inversions, deletions, and insertions).
Title : Operative hysteroscopy: The time to move to office
Ayman A Ewies, Birmingham City Hospital, United Kingdom
Title : Lower genital tract congenital anomalies creatsas vaginoplasty - fertility preservation
George K Creatsas, University of Athens, Greece
Title : Breastfeeding in prevention of postpartum Acute Pancreatitis (AP). A sicilian populationbased case-control study
Alberto Maringhini, ARNAS Civico, Italy
Title : Endometriosis: Gendered pain
Lee Marino Clyne, Mills College, United States
Title : “Just a pinch”? A national survey of provider attitudes regarding IUD procedure analgesia management and options
Nicole Friedlich, Burnett School of Medicine at Texas Christian University, United States
Title : Pregnancy complications: Early intervention identifiers and long-term health support
Amy Loden Tiffany, Vitality Medical and Wellness Consulting, United States